摘要
目的观察他莫昔芬联合抗乳腺增生合剂治疗乳腺增生症的临床疗效。方法 135例确诊的乳腺增生症患者随机分为3组,每组45例。A组给予他莫昔芬治疗,同时给予抗乳腺增生合剂治疗;B组只给予他莫昔芬治疗;C组只给予抗乳腺增生合剂治疗。结果 A组总有效率(93.3%),高于B组(80.0%)和C组(82.3%),A组总有效率分别与B组、C组的总有效率比较,差异有统计学意义(P<0.05)。结论他莫昔芬联合抗乳腺增生合剂治疗乳腺增生症,疗效更好,值得临床推广应用。
Objective To study the clinical effects of tamoxifen combined with kangruxianzengsheng mixture on mam- mary hyperplasia. Methods 135 cases patients with mammary hyperplasia were divided randomly into three groups, every group was 45 cases. Patients in A group were given tamoxifen （10mg PO. qd） and kangruxianzengsheng mixture patients in B group were given tamoxifen only and C group kangruxianzengsheng mixture only. Results The total effective rate of A group （93.3%） was higher than that in B group （80.0%） and C group （82. 3% ）, the differences were statistically significant （P 〈 0. 05） . Conclusion Tamoxifen combined with kangruxianzengsheng mixture is an effective method in the treatment of mam- mary hyperplasia, which is worth utilizing widely in clinic.
出处
《广州医药》
2012年第6期8-9,共2页
Guangzhou Medical Journal
关键词
他莫昔芬
抗乳腺增生合剂
乳腺增生
疗效
Tamoxifen
Kangruxianzengsheng mixture
Mammary hyperplasia
Effect
